Mark de Caestecker
Associate Professor of Medicine
Last active: 10/23/2018

  1. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. Murphy AJ, Pierce J, de Caestecker C, Libes J, Neblett D, de Caestecker M, Perantoni AO, Tanigawa S, Anderson JR, Dome JS, Das A, Carroll TJ, Lovvorn HN (2014) Pediatr Blood Cancer 61(2): 198-205
    › Primary publication · 24115727 (PubMed) · PMC3955491 (PubMed Central)
  2. Ischemia-reperfusion model of acute kidney injury and post injury fibrosis in mice. Skrypnyk NI, Harris RC, de Caestecker MP (2013) J Vis Exp (78)
    › Primary publication · 23963468 (PubMed) · PMC3854859 (PubMed Central)
  3. Histone deacetylase inhibitor enhances recovery after AKI. Cianciolo Cosentino C, Skrypnyk NI, Brilli LL, Chiba T, Novitskaya T, Woods C, West J, Korotchenko VN, McDermott L, Day BW, Davidson AJ, Harris RC, de Caestecker MP, Hukriede NA (2013) J Am Soc Nephrol 24(6): 943-53
    › Primary publication · 23620402 (PubMed) · PMC3665399 (PubMed Central)
  4. HDAC inhibitors in kidney development and disease. Brilli LL, Swanhart LM, de Caestecker MP, Hukriede NA (2013) Pediatr Nephrol 28(10): 1909-21
    › Primary publication · 23052657 (PubMed) · PMC3751322 (PubMed Central)
  5. Deletion of fibroblast growth factor receptor 2 from the peri-wolffian duct stroma leads to ureteric induction abnormalities and vesicoureteral reflux. Walker KA, Sims-Lucas S, Di Giovanni VE, Schaefer C, Sunseri WM, Novitskaya T, de Caestecker MP, Chen F, Bates CM (2013) PLoS One 8(2): e56062
    › Primary publication · 23409123 (PubMed) · PMC3567073 (PubMed Central)
  6. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension. Frump AL, Lowery JW, Hamid R, Austin ED, de Caestecker M (2013) PLoS One 8(11): e80319
    › Primary publication · 24224048 (PubMed) · PMC3818254 (PubMed Central)
  7. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor. Murphy AJ, Pierce J, de Caestecker C, Taylor C, Anderson JR, Perantoni AO, de Caestecker MP, Lovvorn HN (2012) J Pediatr Surg 47(6): 1239-49
    › Primary publication · 22703800 (PubMed) · PMC3377935 (PubMed Central)
  8. Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa. Murphy AJ, Axt JR, de Caestecker C, Pierce J, Correa H, Seeley EH, Caprioli RM, Newton MW, de Caestecker MP, Lovvorn HN (2012) Int J Cancer 131(6): E983-94
    › Primary publication · 22437966 (PubMed) · PMC3402639 (PubMed Central)
  9. Ischemia-reperfusion injury of the mouse kidney. Oxburgh L, de Caestecker MP (2012) Methods Mol Biol : 363-79
    › Primary publication · 22639277 (PubMed)
  10. CITED1 expression in liver development and hepatoblastoma. Murphy AJ, de Caestecker C, Pierce J, Boyle SC, Ayers GD, Zhao Z, Libes JM, Correa H, Walter T, Huppert SS, Perantoni AO, de Caestecker MP, Lovvorn HN (2012) Neoplasia 14(12): 1153-63
    › Primary publication · 23308048 (PubMed) · PMC3540941 (PubMed Central)